Not Signed In - FDA Approves MIRAPEX For The Treatment Of Moderate-to-Severe Primary Restless Legs Syndrome
Sat, 11 Nov 2006 08:00 AM EST
... Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex(R) (pramipexole dihydrochloride) tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS). RLS is a common, yet often undiagnosed, neurological sensorimotor disorder. [click link for full article] ...
Related Topics
- Restless Legs Syndrome
- Restless Legs Syndro
- Pulmonary Hypertension
- Primary
- Cervical Dysplasia
- Primary Care
- Carpal Tunnel Syndrome
- Immune Deficiency
- Tourette Syndrome
- Restless Leg Syndrome
- Lymphedema
- Syndrome X
- Severe Acute Respiratory Syndrome (SARS)
- Asperger's Syndrome
- Down Syndrome
- Marfan Syndrome
- Metabolic Syndrome
- Williams Syndrome
- Amenorrhea
- Klinefelter's Syndrome
email this page
print this page
bookmark this page
feedback on this page
